Lidocaine hydrochloride
- Product NDC
- 17856-0138
- Requested package NDC
- 17856-0138-1
- 11-digit product format
- 178560138
- Labeler code
- 17856
- Product ID
- 17856-0138_34f4d3da-f769-0bdd-e063-6394a90a3fa1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lidocaine hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL; TOPICAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- ANDA216780
- Marketing category
- ANDA
- Marketing start
- 2023-03-28
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216780-001 | LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216780-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | 2023-03-28 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | 2023-03-28 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | 2023-03-28 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | 2023-03-28 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | 2023-03-28 | 053a50430f4f… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216780-001 | LIDOCAINE HYDROCHLORIDE | 2% | SOLUTION / ORAL | AT | RS | 2023-03-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216780-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216780-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216780-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216780-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216780-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216780-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216780-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216780-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216780-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216780-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216780-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216780-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216780-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216780-001 | AT | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216780-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216780-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216780-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216780-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216780-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216780-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216780-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216780-001 | AT | 1 | 053a50430f4f… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216780-001 | AT | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lidocaine hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 20 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1010739 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 75d17334-6876-42d0-8a02-82669d139e4f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0138-1 | Lidocaine hydrochloride | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0138-2 | Lidocaine hydrochloride | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0138-3 | Lidocaine hydrochloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 3 | |
| 17856-0138-4 | Lidocaine hydrochloride | 20 mL in 1 CUP, UNIT-DOSE | SOLUTION | 20 | 3 | |
| 17856-0138-5 | Lidocaine hydrochloride | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-0138-6 | Lidocaine hydrochloride | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0138-1 | ML - Milliliter | 17856-0138 | c494c261-df59-4696-919e-e062bcc63ab6 | 1 | 2024-03-12 |
| 17856-0138-2 | ML - Milliliter | 17856-0138 | c72c7dce-4880-4309-b60c-c5d0f465dce5 | 1 | 2024-03-12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0138 | LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 6 package rows | 20250514_75d17334-6876-42d0-8a02-82669d139e4f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 55aa77b8-7601-4432-8631-bfec58daf247 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | adc4dd69-45f3-48fe-bf85-f014b384c38e | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Advagen Pharma Ltd | ae40021b-8df8-4b16-aac0-dcec88f76c7d | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | e67dee40-b243-4d6b-bc6b-e52c6cb798b8 | 2025-11-01 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Atlantic Biologicals Corp. | 401ecb6c-392b-1d74-e063-6294a90a4005 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | American Health Packaging | 0a36a6de-40d5-41ba-bb5f-39d36c267b7f | 2025-09-02 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP. | 75d17334-6876-42d0-8a02-82669d139e4f | 2025-05-12 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 17856-0138-1 17856-0138 17856013801 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 037764d3-da0e-5ebb-e063-6294a90ab6e0 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | 216780 ANDA216780 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1010739 | lidocaine HCl 2 % Mucous Membrane Topical Solution | PSN | 75d17334-6876-42d0-8a02-82669d139e4f | 3 |
| 1010739 | lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution | SCD | 75d17334-6876-42d0-8a02-82669d139e4f | 3 |
| 1010739 | lidocaine HCl 2 % Oral Topical Solution | SY | 75d17334-6876-42d0-8a02-82669d139e4f | 3 |
| 1010739 | lidocaine HCl 2 % Oromucosal Solution | SY | 75d17334-6876-42d0-8a02-82669d139e4f | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 17856-0138-1 | 17856013801 | 50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0138-1) / 15 mL in 1 CUP, UNIT-DOSE (17856-0138-3) | 2023-09-19 | No | No | Current |